PMID: 9420131Jan 7, 1998Paper

Immunotherapy vs inhaled budesonide in bronchial asthma: an open, parallel, comparative trial

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
W A Shaikh

Abstract

Budesonide, an inhaled corticosteroid and specific immunotherapy, are both routinely used in the treatment of bronchial asthma. However, there are as yet, no studies comparing the effects of budesonide vs immunotherapy. The aim of this study is to compare the effects of budesonide with immunotherapy in patients having perennial asthma. This study is an open, parallel, comparative trial, in which 51 young patients were administered either immunotherapy or budesonide for 1 year and their global symptom scores and FEV1 values assessed. Both treatments were abruptly discontinued after 12 months and the effects of cessation analysed. The use of budesonide resulted in a faster and more striking improvement during the first few months as compared to immunotherapy, with an even more rapid decline in benefits on cessation of budesonide. Immunotherapy on the other hand, resulted in slow but steady improvement which did not decline as rapidly as budesonide on cessation. Although this was an open trial, it could be concluded that relief with inhaled corticosteroids in bronchial asthma is more rapid than immunotherapy; however the decline in benefit on cessation of inhaled corticosteroid is even more rapid, a phenomenon not seen with immuno...Continue Reading

Citations

Apr 1, 2009·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Deepsikha SrivastavaBhanu Pratap Singh
Feb 12, 2009·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Maurizio MarognaGiovanni Passalacqua
Oct 4, 2007·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Deepsikha SrivastavaShailendra N Gaur
Oct 28, 1999·Allergy·M AbramsonJ Weiner
Dec 4, 2013·Current Opinion in Pulmonary Medicine·Enrico CompalatiGiorgio W Canonica
Nov 14, 2013·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Giovanni Passalacqua
May 19, 2010·Expert Review of Respiratory Medicine·Peter J Helms
Oct 25, 2011·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Giovanni Passalacqua
Mar 5, 2010·The Journal of Allergy and Clinical Immunology·Anthony J Frew
Sep 7, 2007·Mayo Clinic Proceedings·Matthew A Rank, James T C Li
Jan 13, 2009·Pediatric Clinics of North America·Paul D Robinson, Peter Van Asperen
Mar 20, 2004·Pediatric Pulmonology. Supplement·Peter N Le Souëf
Jan 25, 2011·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·G Passalacqua, G W Canonica
Sep 4, 2014·International Forum of Allergy & Rhinology·William R Reisacher
Feb 13, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·T Haahtela

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.